New metalloenzyme system selectively targets cancer cells
Specific targeting of cancer cells and onsite drug synthesis has been achieved using a new artificial metalloenzyme delivery system.
Jul 2
Specific targeting of cancer cells and onsite drug synthesis has been achieved using a new artificial metalloenzyme delivery system.
Jun 27
Boosting betaine may be a treatment for schizophrenia
Supplementing model mice with glycine betaine (trimethylglycine), a compound originally derived from beets, can alleviate symptoms of schizophrenia.
Jun 19
Gray matter volume links symptoms in autism
Low gray matter volume in the posterior superior parietal lobule (pSPL) was found to correlate with specific cognitive and perceptual symptoms of autism.
Jun 6
CAPON links Alzheimer’s plaques to neurodegeneration
CAPON was found to link Aβ plaques and hippocampal neurodegeneration in mice, explaining how these two hallmarks of Alzheimer’s disease are related.
May 20
AdR blockers protect the brain from stroke damage
Treatment with adrenergic receptor antagonists (AdR blockers) was able to reduce stroke-related brain damage in mice and improve motor recovery.
Apr 25
Trigger region found for epileptic absence seizures
A mouse model shows that absence seizures are triggered by faulty connections between the cortex and fast-spiking neurons in the striatum.
RIKEN at a Glance
30-day trend
- August 29, 2025
Smoker gut bacteria reduce bowel inflammation in ulcerative colitis - November 26, 2020
Bacterial drug resistance studied by robotic E. coli evolution - August 28, 2025
Eco-friendly method yields more hydrogen storage, more ammonia - July 31, 2025
Meeting robots with hearts and minds of their own at the Osaka Expo - April 11, 2024
Cubes of brain tissue allow drug discovery without animals
Topics
